Print this page

Quality of Life Outcomes of Transurethral Resection of Bladder Tumor and Intravesical Therapy in Non-Muscle Invasive Bladder Cancer

a. Use an adapted validated questionnaire to assess the impact of transurethral resection of bladder tumor and type/ duration of intravesical therapy on the quality of life of patients with non-muscle invasive bladder cancer
b. Quantify development of and changes in patients symptoms over time while undergoing endoscopic and intravesical treatments for non-muscle invasive bladder cancer
c. Correlate symptoms based on patient characteristics, cancer characteristics, treatment type, and treatment duration

Protocol Number: 002450
Phase: N/A
Applicable Disease Sites: Urinary Bladder
Principal Investigator: Vignesh Packiam
Scope: Local
Participating Institutions:
  • RWJBarnabas Health
    • Robert Wood Johnson University Hospital, New Brunswick

For further information about clinical trials, please contact us at 732-235-7356.